socalTECH

APRIL 5, 2013

However, it looks like the acquisition of San Diego''s Amylin Pharmaceuticals by Bristol-Myers Squibb is turning out not-so-great for employees in the location, after news that Bristol-Myers Squibb plans to close its San Diego operations , resulting in the loss of hundreds of jobs. READ MORE>>.

San Diego 153

San Diego Layoffs News Acquisition 153

socalTECH

JANUARY 16, 2013

Lockerz , the Seattle-based social shopping and e-commerce site backed by Kleiner Perkins Caufield & Byers, has axed the company's San Diego office, in addition to laying off around 30 percent of its staff.

San Diego 164

San Diego Commerce Acquisition Sites 164

Xconomy

JULY 10, 2019

Eight years after San Diego biotech Prometheus Laboratories was acquired by Nestlé Health Science , the diagnostic business has been sold again, this time to a little-known biotech called Precision IBD that plans to lay off approximately a quarter of Prometheus’s workforce.

Layoffs 91

Layoffs San Diego Develop Development 91

socalTECH

JUNE 8, 2017

San Diego-based Inseego , the developer of the MiFi wireless hotspots, has aborted its plans to sell off its MiFi division to Chinese company TCL Industries Holdings (H.K.) Limited , and has embarked on a massive restructuring of the company. Inseego said it would immediately recommit to the Mi-Fi business. READ MORE>>.

Sales 113

Sales Technical Review San Diego Acquisition 113

socalTECH

SEPTEMBER 27, 2016

San Diego-based audio technology developer Turtle Beach said Monday that it is restructuring its HyperSound business, in a bid to lower the operating costs of that business. Turtle Beach is a developer of gaming headsets for the Xbox One, PlayStation 4, and other platforms. READ MORE>>.

San Diego 100

San Diego Platform Invest Technology 100

Xconomy

OCTOBER 7, 2016

. —Sarepta Pharmaceuticals (NASDAQ: SRPT ) struck a second deal in as many weeks to develop combination therapies for Duchenne muscular dystrophy. —Ra Pharma filed for an IPO , looking for more cash as it prepares to take on rare disease drug developer Alexion Pharmaceuticals (NASDAQ: ALXN ). Image “U.S.

Technical Review 77

Technical Review Study Layoffs San Diego 77

Xconomy

JULY 1, 2016

If you want fireworks this weekend, you can either celebrate the 4th of July or watch the latest post-Brexit political developments in Britain. AstraZeneca’s olaparib (Lynparza) became the first approved PARP drug in 2014, and several others are being developed, including talazoparib from San Francisco’s Medivation (NASDAQ: MDVN ).

Buzzfeed 59

Buzzfeed News Pricing IBM 59